Regulatory delays in UK collections deal
A large UK collections deal was delayed by a quarter due to regulatory approvals, impacting Q4 revenue. Though now live, similar delays could recur.
medium · management_commentaryFirstsource delivered a strong Q4 FY26, with revenue of ₹25.8B (up 19.5% YoY) and PAT of ₹2.1B (up 27.7% YoY).
✓ Verified against BSE filing
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
A large UK collections deal was delayed by a quarter due to regulatory approvals, impacting Q4 revenue. Though now live, similar delays could recur.
medium · management_commentaryTighter regulatory environment for Medicare Advantage plans caused payers to pause program rollouts, creating a short-term timing impact on healthcare revenue.
medium · management_commentaryAnalyst questioned potential deflation from AI productivity; management acknowledged efficiency gains but argued TAM expansion offsets. Risk remains if outcome-based pricing scales slower.
medium · analyst_questionCMT revenue declined 4% QoQ due to timing of work packets and program transitions in consumer tech; management expects normalization but volatility persists.
low · data_observation